Markwell LLP

What We Do

Welcome To

Markwell LLP

We are a drug regulatory and patent litigation law firm in Toronto, Canada.

In our patent litigation practice, we represent companies across a wide-range of industries in infringement, validity, and damages actions before the Federal Court, including cases under the Patented Medicines (Notice of Compliance) Regulations. We also provide legal opinions, settlement counsel, and due diligence support in transactions involving patents.

In our regulatory litigation practice, we represent innovative pharmaceutical and biotechnology companies in disputes with the government and private payers relating to the manufacture, use and sale of drug products in Canada, including clinical trials, product approvals, data protection, patent term restoration, patent listings (PMNOC), pricing (PMPRB), health technology assessments, and formulary listings.



Our Lawyers

Jason Markwell

Jason is a patent and drug regulatory litigation lawyer in Toronto. He was called to the Ontario bar in 1999. Jason draws on his years of experience as a lawyer in leading law firms to provide clients with practical advice to meet their commercial goals.

Jason has appeared as counsel in many precedent-setting cases before the Supreme Court of Canada, the Federal Court of Appeal, the Federal Court, the Ontario Superior Court of Justice, and the Patented Medicine Prices Review Board. Jason has been recognized as a leading intellectual property lawyer by Chambers & Partners, IAM Patent 1000, The Best Lawyers Canada, Who’s Who Legal, IP Stars, Martindale Hubbell, Lexpert (consistently recommended in Intellectual Property, Litigation-Intellectual Property, and Life Sciences), Benchmark Litigation (IP Litigator of the Year, 2017), The Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada, Managing Intellectual Property (Outstanding IP Practitioner – Canada, 2019), and LMG Life Sciences (Lawyer of the Year, 2018, Patent Litigation). Jason is active in various intellectual property organizations, including the Intellectual Property Institute of Canada (IPIC) and the International Association for the Protection of Intellectual Property (AIPPI Standing committee on Biotechnology).

Read more

Rebecca Crane

Rebecca is a drug regulatory and patent litigation lawyer in Toronto who applies both her legal and scientific expertise to strategically advise and support clients. Rebecca received her JD from the University of Toronto in 2005 and was called to the bar in 2006. Rebecca also obtained a Ph.D. in microbiology from the University of Guelph.

Rebecca’s Ph.D. dissertation focused on the purification and characterization of osmoregulatory proteins of Escherichia coli. She has significant research experience in biochemistry, molecular biology, and microbiology. Prior to joining Markwell LLP, Rebecca practised at several leading law firms in their patent litigation groups. Rebecca’s legal and scientific background allows her to uniquely understand clients’ technology, business objectives, and product portfolios in support of their patent litigation and regulatory matters. Rebecca frequently represents life sciences and pharmaceutical industry clients in patent litigation matters and strategic product regulatory advice, including on matters related to Canada’s Patented Medicines Prices Review Board (PMPRB). Since 2021, Rebecca has been selected as one of Canada’s best patent professionals in the IAM Patent 1000 rankings.

Read more